Zecotek Receives European and Eurasian Patent Allowance for 3D Display System
Singapore, May 22, 2012 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the European Patent Office has issued a Notice of Allowance, and the Eurasian Patent Office has issued a Notification on Readiness to Grant a Eurasian Patent, for the 3D/2D switchable optical imaging system for its glasses-free 3D auto-stereoscopic display system. The European Notice of Allowance and the Eurasian Notification on Readiness add to the other global patents, including U.S. patent number 7,944,465 covering glasses-free 3D auto-stereoscopic display system, strengthening Zecotek’s worldwide patent position as the Company moves to fully commercialize its innovative 3D technology and other photonics technology.
“We take considerable care in the protection of our intellectual property and receiving the Notice of Allowance from the European Union for our glasses-free 3D display system is very important to the overall commercialization of this valuable technology,” said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. “Our 3D auto-stereoscopic display offers a real volumetric 3D viewing experience with one of the widest viewing angles and the highest resolution compared to competing technologies, and it is critical that the IP be protected. Our objective is to pursue full commercialization of our 3D technology with a strategic partner.”
The European patent allowance includes all countries of the European Union. The Eurasia Patent Organization includes 9 former-Soviet nations: Russian Federation, Republic of Kazakhstan, Turkmenistan, Kyrgyz Republic, Republic of Belarus, Republic of Tajikistan, Republic of Azerbaijan, Republic of Moldova and Republic of Armenia. The European and Eurasian patent allowances cover the 3D/2D switchable optical imaging system of Zecotek’s Real-Time 3D Display. The 3D/2D switchable optical imaging system further improves the core capabilities of the 3D display technology by introducing a software-selectable full-resolution 2D mode with viewing angles and dynamic range/colour depth on par with conventional 2D displays. The patent covers technology for both 3D and 2D modes, dynamic adjustment of viewing angle, number and width of viewing zones as well as the functionality to dynamically control the positioning of different viewing zones.
Zecotek’s “patented” Real-Time 3D Display System is based on the auto-stereoscopic principle, but with substantial innovative. It has the capability of simultaneously presenting to multiple users both 3D and 2D images on the same screen with separate views and at different viewing angles. The 3D display system provides comfortable conditions for viewing a volumetric representation without eye strain. The viewing of such 3D images does not require the use of any supplementary means such as glasses, does not drastically limit the position of the viewer with respect to the display, and allows simultaneous viewing of the 3D display by many viewers from a sufficiently wide field of view.
Patents have now been granted to Zecotek for its 3D display system in Europe, Eurasia, the United States and Australia. Patents have been filed and are pending in Japan, China, Korea, and India.
The Company also announces, effective immediately, Dr. Serge Khorev will no longer act as Senior Vice President, Technology. Dr. Khorev reassumes his original position of Senior Technology Analyst with the Company.
About Zecotek’s Real-Time 3D Display System
Zecotek’s 3D Display System is based on the auto-stereoscopic principle, but with substantial innovative and patented improvements and represents a new and unique generation of 3D displays. It has the capability of simultaneously presenting 3D and 2D images on the same screen, and for separate views at different viewing angles. Zecotek’s true, auto-stereoscopic 3D2D display system requires no eyewear and has an effective viewing angle of 40 degrees with 90 concurrent perspectives allowing for multiple views at the same time. Another unique feature of the Zecotek system is constant motion parallax within the viewing angle. Motion parallax eliminates the sense of imbalance and dizziness during normal observation which can occur with polarized and shutter glasses used with other commercial systems.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: medical imaging, medical lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
T: (604) 783-8291
CHF Investor Relations
Julia Clark, Account Manager
T: (416) 868-1079 x236
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.